Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-12-05
1999-02-16
Reamer, James H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514174, A61K 31335
Patent
active
058721479
ABSTRACT:
The subject invention provides a method of treating a symptom associated with chronic obstructive pulmonary disease in a patient suffering from chronic obstructive pulmonary disease which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The subject invention further provides a method of improving functional capacity and/or pulmonary function in a patient suffering from chronic obstructive pulmonary disease which comprises administering a therapeutically effective amount of an oxandrolone to the patient.
REFERENCES:
patent: 3128283 (1964-04-01), Pappo
patent: 4039668 (1977-08-01), Fuchs et al.
patent: 4376733 (1983-03-01), Frimer
patent: 4914106 (1990-04-01), Shibata et al.
patent: 5096916 (1992-03-01), Skupin
Desforges, Current Concepts, vol. 328, pp. 1017-1022, 1993.
New England J. of Med., pp. 1017-1021, 1993.
Ann of Intern. Med., vol. 114, pp. 216-223, 1991.
Bio-Technology General Corp.
Reamer James H.
White John P.
LandOfFree
Use of oxandrolone in the treatment of chronic obstructive pulmo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of oxandrolone in the treatment of chronic obstructive pulmo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of oxandrolone in the treatment of chronic obstructive pulmo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2062813